在患有婴儿的患者中,脉冲性德克萨米他:对独特治疗方案的回顾性分析
Dennis Reimer1, Ulrich Brandl1, Heike De Vries1
1Klinik für Neuropädtiatrie, Jena, Germany.
Neuropediatrics
|January 27, 2025
概括
对婴儿 (IS) 的脉冲性德克萨米他治疗是安全有效的,在许多婴儿中实现了无. 结果与其他激素治疗相似,病因是关键因素.
科学领域:
- 儿科神经学 儿科神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 婴儿 (IS) 是婴儿的一种严重综合征.
- 早期和持续控制是最佳结果的关键.
- 目前的治疗方法旨在快速停止.
研究的目的:
- 为了评估一个独特的脉动性德克萨米他治疗方案用于婴儿.
- 评估这种治疗方法的有效性和安全性.
- 分析长期的神经发育和的结果.
主要方法:
- 对26名IS儿童进行了回顾性分析,这些儿童接受了脉动性口服德甲治疗.
- 治疗包括标准 (5-7天) 或延长 (10-14天) 的初始脉冲.
- 评估的结果包括缩减少,EEG反应,不良事件和神经发育状态.
主要成果:
- 69.2%的患者实现了最初的发作自由,而38.9%的患者出现了复发.
- 在82.4%的病例中,延长的初始脉冲导致了发作自由.
- 在最后一次随访时,一半的患者没有持续性性疾病;22.2%的患者表现出良好的神经认知发育.
- 未知病因与更好的控制和神经认知结果有关.
结论:
- 脉冲性德克萨米他治疗是婴儿的安全治疗方法.
- 治疗结果与标准激素疗法可比.
- 婴儿的病因是影响结果的最重要因素.
相关概念视频
Skeletal Muscle Relaxants: Adverse Effects
332
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
332
Skeletal Muscle Relaxants: Therapeutic Uses
462
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
462
Depolarizing Blockers: Pharmocokinetics
305
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
305


